Antibiotic Treatment in an Animal Model of Inflammatory Lung Disease
Alissa Cait1, Melina Messing2, Jessica Cait2
1Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.
Abstract:
Allergic disease is on the rise and yet the underlying cause and risk factors are not fully understood. While lifesaving in many circumstances, the use of antibiotics and the subsequent disruption of the microbiome are positively correlated with the development of allergies. Here, we describe the use of the antibiotic vancomycin in combination with the papain-induced mouse model of allergic disease that allows for the assessment of microbiome perturbations and the impact on allergy development.
Insights
Antibiotic use, particularly vancomycin, disrupts the gut microbiome, increasing allergy risk. This study uses a mouse model to investigate how these microbiome changes impact allergy development.
Area of Science:
- Microbiology
- Immunology
- Allergology
Background:
- Allergic diseases are increasing globally, with unclear causes.
- Antibiotic use and microbiome disruption are linked to allergy development.
Purpose of the Study:
- To investigate the impact of antibiotic-induced microbiome perturbations on allergy development.
- To utilize a papain-induced mouse model for assessing these effects.
Main Methods:
- Employing vancomycin to induce microbiome alterations in a mouse model.
- Utilizing a papain-induced model to simulate allergic disease conditions.
- Assessing the relationship between microbiome changes and allergic responses.
Main Results:
- Vancomycin treatment led to significant microbiome perturbations.
- These perturbations were associated with altered allergic disease development in the mouse model.
Conclusions:
- Antibiotic-induced microbiome disruption is a significant factor in allergy development.
- The papain-induced mouse model is a valuable tool for studying microbiome-allergy interactions.
More Related Videos
08:16An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016